Presenter: Dr. Robert Bridwell, MD, MBA Medical Advisor at SOFIE Dr. Robert Bridwell, medical advisor to SOFIE, and co-founder of PETLinQ, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging, utilizing physician empowerment training, protocol development assistance, and quality assurance guidelines. In the last five years, Dr. Bridwell has been invited to make numerous presentations, which have included more than 1200 hours of CME credit delivered to more than 350 institutions, 100 professional society meetings and more than 150 radiology groups throughout the United States, Canada and Europe.
Date: March 27, 2025
Time: 3:30pm – 4:30pm EDT
In this session, Dr. Bridwell will help you to:
- understand the role of imaging and CSF biomarkers to identify patients for anti amyloid therapy
- understand the role of Centiloid scoring to improve interpreter confidence as well as to follow patients on therapy
- understand the clinical management pathway for patients on anti amyloid therapy
- review the pitfalls of imaging and interpretation
THIS ACTIVITY IS APPROVED FOR 1.0 CEH CREDIT BY SNMMI